NCT03515759

Brief Summary

60 pregnant women with singleton living fetus between 34 -38 wks gestation known to have severe hypertension in the current pregnancy were included. All participants underwent Doppler ultrasonography to evaluate the Feto-Placental Circulation within 24 hours from Pregnancy Termination. Flow Velocity Waveforms were obtained from: Umbilical Artery (UA), Middle Cerebral Artery (MCA), Ductus Venosus (DV), Umbilical Vein (UV). From the flow velocity waveforms the following indices were measured: UA \& MCA: Pulsatility Index (PI) \& Resistance Index (RI), DV: Peak Velocity Index For veins (PVIV), Peak Systolic Velocity (PSV) \& a- wave. UV Flow: Presence or Absence of Pulsatile Flow.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Nov 2017

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2017

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

April 23, 2018

Completed
11 days until next milestone

First Posted

Study publicly available on registry

May 4, 2018

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 15, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 15, 2019

Completed
Last Updated

February 15, 2019

Status Verified

April 1, 2018

Enrollment Period

1.2 years

First QC Date

April 23, 2018

Last Update Submit

February 11, 2019

Conditions

Keywords

PREECLAMPSIADOPPLERIUGRUMBILICAL ARTERYMIDDLE CEREBRAL ARTERY

Outcome Measures

Primary Outcomes (1)

  • The diagnostic value of umbilical artery (UA) Doppler indices (RI & PI) in predicting adverse perinatal outcome among severely hypertensive patients

    sensitivity and specificity of umbilical artery RI \& PI in detecting IUGR and APGAR score less than 7 at 5 minutes

    within 24 hours before delivery and post natal

Secondary Outcomes (3)

  • The diagnostic value of Middle cerebral artery (MCA) Doppler indices (RI & PI) in predicting adverse perinatal outcome among severely hypertensive patients

    within 24 hours before delivery and post natal

  • The diagnostic value of cerebro/placentaI Ratio in predicting adverse perinatal outcome among severely hypertensive patients.

    within 24 hours before delivery and post natal

  • The diagnostic value of Ductus Venousus Doppler indices in predicting adverse perinatal outcome among severely hypertensive patients.

    within 24 hours before delivery and post natal

Study Arms (1)

hypertensive patients

60 pregnant women with singleton living fetus between 34 -38 wks gestation known to have severe hypertension in the current pregnancy were included

Eligibility Criteria

Age18 Years - 35 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

60 pregnant women with singleton living fetus between 34 -38 wks gestation known to have severe hypertension in the current pregnancy were included.

You may qualify if:

  • Gestational age (GA): 34 - 38weeks of gestations (confirmed by a reliable date for the last menstrual period or /and 1st trimester ultrasound scan).
  • The current Pregnancy complicated with severe hypertension (gestational hypertension, preeclampsia, chronic hypertension and chronic hypertension with superimposed preeclampsia).
  • Singleton living fetus.

You may not qualify if:

  • Maternal medical disorders rather than hypertension.
  • Fetal congenital anomalies.
  • Rupture of membrane.
  • Antepartum hemorrhage (placenta previa or accidental hemorrhage).
  • The maternal administration of respiratory depressants within 2 hours from the delivery of the fetus (e. g., opioid analgesic )

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Kasr Elainy Hospital (Faculty of Medicine - Cairo University)

Cairo, 115431, Egypt

Location

MeSH Terms

Conditions

Pre-Eclampsia

Condition Hierarchy (Ancestors)

Hypertension, Pregnancy-InducedPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital Diseases

Study Officials

  • moutaz elsherbini, MD

    Assistant professor of obstetrics and gynecology

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
assistant professor

Study Record Dates

First Submitted

April 23, 2018

First Posted

May 4, 2018

Study Start

November 1, 2017

Primary Completion

January 15, 2019

Study Completion

January 15, 2019

Last Updated

February 15, 2019

Record last verified: 2018-04

Locations